Agree with your speculation as apposed to a buyout

Agree with your speculation as apposed to a buyout at this time. Way too early for buyout talks. KEVETRIN has to prove itself in the testing, THEN,  CTIX management can seek or hear outside options. Would be selling cheap at this time. For us as investors EVERYTHING at this time hinges on documentation that KEVETRIN works and that requires a report of tumor shrinkage. Being PRURISOL has been delayed till this fall, that is what we will see first. The only real thing we know at this time is the study at DF is still ongoing.